JNJ vs NVO: six-factor score, head to head
How Johnson & Johnson and NVOcompare on Tapeline’s published six-factor composite score. Descriptive only — a rules-based reading of each name, not a recommendation.
Today, JNJ scores 64 and NVO scores 52on Tapeline’s six-factor composite. JNJ carries the higher composite score today. Here’s how the six factors line up.
| Factor | JNJ | NVO |
|---|---|---|
| Trend | 94 | 73 |
| Relative Strength | 65 | 30 |
| Fundamentals | 80 | — |
| Smart Money | 38 | — |
| Macro | 32 | 75 |
| Momentum | 47 | 15 |
JNJ · Health Care
smart-money factor near the top of its range; trend factor on the lower side of its range.
NVO · Health Care
No reason text available.
The Tapeline Score is a descriptive, rules-based measure for information only — not investment advice or a recommendation to buy or sell. See the six-factor method and the public scorecard.
More comparisons
FAQ
- How do JNJ and NVO compare on Tapeline?
- Tapeline scores JNJ 64/100 and NVO 52/100 on its published six-factor composite (trend, relative strength, fundamentals, smart money, macro, momentum). The page breaks the two scores down factor by factor.
- Which has the higher Tapeline score, JNJ or NVO?
- JNJ has the higher composite score today (64 vs 52). The score is a descriptive measure, not a recommendation — see the per-factor breakdown above.
- Is this investment advice?
- No. Tapeline publishes a descriptive, rules-based six-factor score for information only. It is not a recommendation to buy or sell, and every top pick is back-checked publicly at /scorecard.